**Core Concept:** Hepatic failure is a condition where the liver is unable to perform its functions, leading to complications and potentially death. Full supportive treatment aims to stabilize the patient until liver transplantation or recovery occurs. The anhepatic phase is a temporary period where the liver function is completely absent or severely reduced, leading to systemic complications.

**Why the Correct Answer is Right:** In the anhepatic phase, patients typically survive for a limited period due to the absence of liver function, which is essential for maintaining homeostasis and detoxifying the body. Full supportive treatment, such as renal replacement therapy, vasoconstrictors, and inotropes, is provided to stabilize vital parameters and prevent life-threatening complications. Although supportive treatment can help stabilize the patient, the survival time in anhepatic phase remains relatively short due to the critical nature of the condition.

**Why Each Wrong Option is Incorrect:**

A. False - The anhepatic phase is a critical condition where survival is limited, regardless of supportive treatment.
B. False - The survival time is not significantly longer with less supportive treatment.
C. False - Survival is dependent on the severity of the anhepatic phase and the effectiveness of supportive treatment, but the core issue remains the absence of liver function.
D. False - Survival time is limited due to the critical nature of the anhepatic phase and absence of liver function, regardless of supportive treatment.

**Clinical Pearl:** The survival time in anhepatic phase is relatively short, highlighting the critical nature of the condition and the importance of early intervention and management. In cases of acute liver failure, organ transplantation or liver regeneration might be necessary to save the patient's life.

**Correct Answer:** D. Survival time in anhepatic phase is limited due to the critical nature of the condition and absence of liver function, regardless of supportive treatment. The supportive treatment aims to stabilize the patient while awaiting liver transplantation or recovery.